June 22, 2020 / 12:50 PM / 11 days ago

BRIEF-Heat Biologics Says First Patient Treated In Co's First-In-Human Phase 1 Clinical Trial Evaluating PTX-35

June 22 (Reuters) - Heat Biologics Inc:

* HEAT BIOLOGICS - FIRST PATIENT HAS BEEN TREATED IN CO’S FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL EVALUATING PTX-35

* HEAT BIOLOGICS - FIRST-IN-HUMAN STUDY OF PTX-35 IS EXPECTED TO ENROLL UP TO 30 PATIENTS WITH ADVANCED SOLID TUMORS REFRACTORY TO STANDARD OF CARE Source text: (bit.ly/2CmsctJ) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below